These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28666923)

  • 1. Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway.
    Hellgren C; Comasco E; Skalkidou A; Sundström-Poromaa I
    Horm Behav; 2017 Aug; 94():106-113. PubMed ID: 28666923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy.
    Hellgren C; Åkerud H; Skalkidou A; Bäckström T; Sundström-Poromaa I
    Neuropsychobiology; 2014; 69(3):147-53. PubMed ID: 24776841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-related genetic polymorphisms in association with peripartum depression symptoms and stress hormones: A longitudinal population-based study.
    Skalkidou A; Poromaa IS; Iliadis SI; Huizink AC; Hellgren C; Freyhult E; Comasco E
    Psychoneuroendocrinology; 2019 May; 103():296-305. PubMed ID: 30776573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias.
    Mares L; Vilchis F; Chávez B; Ramos L
    J Pediatr Urol; 2020 Oct; 16(5):689.e1-689.e12. PubMed ID: 32732174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific association of variants in the AKR1C1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the importance of neurosteroids in anxiety?
    Quast C; Reif A; Brückl T; Pfister H; Weber H; Mattheisen M; Cichon S; Lang T; Hamm A; Fehm L; Ströhle A; Arolt V; Domschke K; Kircher T; Wittchen HU; Pauli P; Gerlach AL; Alpers GW; Deckert J; Rupprecht R; Binder EB; Erhardt A
    Depress Anxiety; 2014 Oct; 31(10):843-50. PubMed ID: 24390875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study.
    Standeven LR; Osborne LM; Betz JF; Yenokyan G; Voegtline K; Hantsoo L; Payne JL
    Arch Womens Ment Health; 2022 Apr; 25(2):521-526. PubMed ID: 34714413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms.
    Björväng RD; Walldén Y; Fransson E; Comasco E; Sundström-Poromaa I; Skalkidou A
    Psychoneuroendocrinology; 2024 Jun; 164():107009. PubMed ID: 38442504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature.
    McEvoy K; Payne JL; Osborne LM
    Curr Psychiatry Rep; 2018 Aug; 20(9):78. PubMed ID: 30094520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between a polymorphism in the hydroxysteroid (11-beta) dehydrogenase 1 gene, neuroticism and postpartum depression.
    Iliadis SI; Comasco E; Hellgren C; Kollia N; Sundström Poromaa I; Skalkidou A
    J Affect Disord; 2017 Jan; 207():141-147. PubMed ID: 27721188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Exposure to Bisphenols and Phthalates and Postpartum Depression: The Role of Neurosteroid Hormone Disruption.
    Jacobson MH; Stein CR; Liu M; Ackerman MG; Blakemore JK; Long SE; Pinna G; Romay-Tallon R; Kannan K; Zhu H; Trasande L
    J Clin Endocrinol Metab; 2021 Jun; 106(7):1887-1899. PubMed ID: 33792735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum.
    Dichtel LE; Lawson EA; Schorr M; Meenaghan E; Paskal ML; Eddy KT; Pinna G; Nelson M; Rasmusson AM; Klibanski A; Miller KK
    Neuropsychopharmacology; 2018 May; 43(6):1436-1444. PubMed ID: 29090684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D levels and perinatal depressive symptoms in women at risk: a secondary analysis of the mothers, omega-3, and mental health study.
    Williams JA; Romero VC; Clinton CM; Vazquez DM; Marcus SM; Chilimigras JL; Hamilton SE; Allbaugh LJ; Vahratian AM; Schrader RM; Mozurkewich EL
    BMC Pregnancy Childbirth; 2016 Aug; 16(1):203. PubMed ID: 27485050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.
    Deligiannidis KM; Kroll-Desrosiers AR; Mo S; Nguyen HP; Svenson A; Jaitly N; Hall JE; Barton BA; Rothschild AJ; Shaffer SA
    Psychoneuroendocrinology; 2016 Aug; 70():98-107. PubMed ID: 27209438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients.
    Luisi S; Petraglia F; Benedetto C; Nappi RE; Bernardi F; Fadalti M; Reis FM; Luisi M; Genazzani AR
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2429-33. PubMed ID: 10902789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis.
    Deligiannidis KM; Kroll-Desrosiers AR; Tan Y; Dubuke ML; Shaffer SA
    Psychoneuroendocrinology; 2020 Nov; 121():104827. PubMed ID: 32828068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.
    Slopien R; Pluchino N; Warenik-Szymankiewicz A; Sajdak S; Luisi M; Drakopoulos P; Genazzani AR
    Gynecol Endocrinol; 2018 Feb; 34(2):144-147. PubMed ID: 28857628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adiponectin and depressive symptoms during pregnancy and the postpartum period: A prospective cohort study.
    Rebelo F; Farias DR; Struchiner CJ; Kac G
    J Affect Disord; 2016 Apr; 194():171-9. PubMed ID: 26826867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GABAergic approach of postpartum depression: A translational review of literature].
    Verbe J; Dubertret C; El-Hage W; Bonnet-Brilhault F; Duriez P
    Encephale; 2020 Apr; 46(2):123-134. PubMed ID: 31767256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive accuracy of Edinburgh postnatal depression scale assessment during pregnancy for the risk of developing postpartum depressive symptoms: a prospective cohort study.
    Meijer JL; Beijers C; van Pampus MG; Verbeek T; Stolk RP; Milgrom J; Bockting CL; Burger H
    BJOG; 2014 Dec; 121(13):1604-10. PubMed ID: 24703235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy.
    Fasching PA; Faschingbauer F; Goecke TW; Engel A; Häberle L; Seifert A; Voigt F; Amann M; Rebhan D; Burger P; Kornhuber J; Ekici AB; Beckmann MW; Binder EB
    J Psychiatr Res; 2012 Sep; 46(9):1109-17. PubMed ID: 22721547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.